Published in Circulation on January 28, 2003
Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer (2010) 11.16
Integrins in angiogenesis and lymphangiogenesis. Nat Rev Cancer (2008) 4.27
Quantitative PET imaging of tumor integrin alphavbeta3 expression with 18F-FRGD2. J Nucl Med (2006) 2.65
Radiation-force assisted targeting facilitates ultrasonic molecular imaging. Mol Imaging (2004) 2.19
Myocardial ischemic memory imaging with molecular echocardiography. Circulation (2007) 2.13
Noninvasive Raman spectroscopy in living mice for evaluation of tumor targeting with carbon nanotubes. Nano Lett (2008) 2.01
Near-infrared fluorescent RGD peptides for optical imaging of integrin alphavbeta3 expression in living mice. Bioconjug Chem (2005) 2.01
On-chip generation of microbubbles as a practical technology for manufacturing contrast agents for ultrasonic imaging. Lab Chip (2007) 1.74
Molecular imaging in atherosclerosis, thrombosis, and vascular inflammation. Arterioscler Thromb Vasc Biol (2009) 1.65
Improving sensitivity in ultrasound molecular imaging by tailoring contrast agent size distribution: in vivo studies. Mol Imaging (2010) 1.63
Why integrin as a primary target for imaging and therapy. Theranostics (2011) 1.61
Microbubble ultrasound contrast agents: an update. Eur Radiol (2007) 1.57
Critical mechanical conditions around neovessels in carotid atherosclerotic plaque may promote intraplaque hemorrhage. Atherosclerosis (2012) 1.56
Tailoring the size distribution of ultrasound contrast agents: possible method for improving sensitivity in molecular imaging. Mol Imaging (2007) 1.55
Primer on molecular imaging technology. Eur J Nucl Med Mol Imaging (2005) 1.55
Ultrasonic analysis of peptide- and antibody-targeted microbubble contrast agents for molecular imaging of alphavbeta3-expressing cells. Mol Imaging (2004) 1.49
Near-infrared fluorescence imaging of tumor integrin alpha v beta 3 expression with Cy7-labeled RGD multimers. Mol Imaging Biol (2006) 1.46
Advances in molecular imaging with ultrasound. Mol Imaging (2010) 1.42
Molecular imaging of vascular endothelial growth factor receptor 2 expression using targeted contrast-enhanced high-frequency ultrasonography. J Ultrasound Med (2007) 1.38
Selective imaging of adherent targeted ultrasound contrast agents. Phys Med Biol (2007) 1.31
Sonoporation by single-shot pulsed ultrasound with microbubbles adjacent to cells. Biophys J (2009) 1.23
A stimulus-responsive contrast agent for ultrasound molecular imaging. Biomaterials (2007) 1.22
Recent trends in antibody-based oncologic imaging. Cancer Lett (2011) 1.17
Asymmetric oscillation of adherent targeted ultrasound contrast agents. Appl Phys Lett (2005) 1.12
Acoustic response from adherent targeted contrast agents. J Acoust Soc Am (2006) 1.11
Assessment of molecular imaging of angiogenesis with three-dimensional ultrasonography. Mol Imaging (2011) 1.11
Clinical applications of perfluorocarbon nanoparticles for molecular imaging and targeted therapeutics. Int J Nanomedicine (2007) 1.09
MicroPET imaging of integrin αvβ3 expressing tumors using 89Zr-RGD peptides. Mol Imaging Biol (2011) 1.08
Molecular imaging of cardiovascular disease with contrast-enhanced ultrasonography. Nat Rev Cardiol (2009) 1.08
Molecular imaging of cardiovascular disease using ultrasound. J Nucl Cardiol (2008) 1.06
The high angiogenic activity in very early breast cancer enables reliable imaging with VEGFR2-targeted microbubbles (BR55). Eur Radiol (2012) 1.04
Micro-ultrasound for preclinical imaging. Interface Focus (2011) 1.02
Molecular imaging of disease with targeted contrast ultrasound imaging. Transl Res (2012) 1.02
Ultrasound assessment of angiogenesis in a matrigel model in rats. Ultrasound Med Biol (2006) 1.02
Molecular imaging with targeted perfluorocarbon nanoparticles: quantification of the concentration dependence of contrast enhancement for binding to sparse cellular epitopes. Ultrasound Med Biol (2007) 1.00
Molecular imaging of endothelial progenitor cell engraftment using contrast-enhanced ultrasound and targeted microbubbles. Cardiovasc Res (2009) 0.98
Contrast-enhanced ultrasound for molecular imaging of angiogenesis. Eur J Nucl Med Mol Imaging (2010) 0.97
Fast microbubble dwell-time based ultrasonic molecular imaging approach for quantification and monitoring of angiogenesis in cancer. Quant Imaging Med Surg (2012) 0.96
Ultrasound molecular imaging of cardiovascular disease. Nat Clin Pract Cardiovasc Med (2008) 0.96
Application of molecular ultrasound for imaging integrin expression. Theranostics (2011) 0.94
Molecular imaging of inflammation and intraplaque vasa vasorum: a step forward to identification of vulnerable plaques? J Nucl Cardiol (2010) 0.93
PET Imaging of Integrin Positive Tumors Using F Labeled Knottin Peptides. Theranostics (2011) 0.92
Optical imaging of the adoptive transfer of human endothelial cells in mice using anti-human CD31 monoclonal antibody. Pharm Res (2007) 0.91
Targeted nanotechnology for cancer imaging. Adv Drug Deliv Rev (2014) 0.91
Imaging angiogenesis of genitourinary tumors. Nat Rev Urol (2010) 0.90
Real-time targeted molecular imaging using singular value spectra properties to isolate the adherent microbubble signal. Phys Med Biol (2012) 0.90
Systemic delivery of a breast cancer-detecting adenovirus using targeted microbubbles. Cancer Gene Ther (2012) 0.89
A comparative evaluation of ultrasound molecular imaging, perfusion imaging, and volume measurements in evaluating response to therapy in patient-derived xenografts. Technol Cancer Res Treat (2013) 0.87
Targeted renal therapies through microbubbles and ultrasound. Adv Drug Deliv Rev (2010) 0.87
Contrast enhanced maximum intensity projection ultrasound imaging for assessing angiogenesis in murine glioma and breast tumor models: A comparative study. Ultrasonics (2010) 0.86
Leveraging the power of ultrasound for therapeutic design and optimization. J Control Release (2011) 0.85
Toward ultrasound molecular imaging with phase-change contrast agents: an in vitro proof of principle. Ultrasound Med Biol (2013) 0.85
Evolution of contrast agents for ultrasound imaging and ultrasound-mediated drug delivery. Front Pharmacol (2015) 0.85
Nanoparticle delivery enhancement with acoustically activated microbubbles. IEEE Trans Ultrason Ferroelectr Freq Control (2013) 0.84
Intravascular targets for molecular contrast-enhanced ultrasound imaging. Int J Mol Sci (2012) 0.83
Disintegrins from snake venoms and their applications in cancer research and therapy. Curr Protein Pept Sci (2015) 0.83
Ultrasonic imaging of endothelial CD81 expression using CD81-targeted contrast agents in in vitro and in vivo studies. Ultrasound Med Biol (2012) 0.82
Model system using controlled receptor expression for evaluating targeted ultrasound contrast agents. Ultrasound Med Biol (2011) 0.82
An in vivo evaluation of the effect of repeated administration and clearance of targeted contrast agents on molecular imaging signal enhancement. Theranostics (2013) 0.80
Intravascular ultrasound catheter to enhance microbubble-based drug delivery via acoustic radiation force. IEEE Trans Ultrason Ferroelectr Freq Control (2012) 0.80
Recent developments in dynamic contrast-enhanced ultrasound imaging of tumor angiogenesis. Imaging Med (2014) 0.80
Future applications of contrast ultrasound. J Cardiovasc Ultrasound (2011) 0.80
Preparation of human hepatocellular carcinoma-targeted liposome microbubbles and their immunological properties. World J Gastroenterol (2004) 0.78
Microbubbles and ultrasound: a bird's eye view. Trans Am Clin Climatol Assoc (2004) 0.78
Cardiovascular molecular imaging with contrast ultrasound: principles and applications. Korean Circ J (2014) 0.77
Imaging of angiogenesis in cardiology. Eur J Nucl Med Mol Imaging (2007) 0.76
Improving the efficacy of therapeutic angiogenesis by UTMD-mediated Ang-1 gene delivery to the infarcted myocardium. Int J Mol Med (2015) 0.76
Molecular Imaging Probe Development using Microfluidics. Curr Org Synth (2011) 0.76
Local drug and gene delivery through microbubbles and ultrasound. Neth Heart J (2004) 0.76
Ultrasound Molecular Imaging of Angiogenesis Using Vascular Endothelial Growth Factor-Conjugated Microbubbles. Mol Pharm (2017) 0.75
Molecular Imaging of Angiogenesis and Vascular Remodeling in Cardiovascular Pathology. J Clin Med (2016) 0.75
Vascular targeting of nanoparticles for molecular imaging of diseased endothelium. Adv Drug Deliv Rev (2016) 0.75
Design of Albumin-Coated Microbubbles Loaded With Polylactide Nanoparticles. J Ultrasound Med (2015) 0.75
Accumulation of nano-sized particles in a murine model of angiogenesis. Biochem Biophys Res Commun (2013) 0.75
Ultrasound combined with targeted cationic microbubble-mediated angiogenesis gene transfection improves ischemic heart function. Exp Ther Med (2017) 0.75
Contrast-Enhanced Ultrasound Reveals Exercise-Induced Perfusion Deficits in Claudicants. J Vasc Endovasc Surg (2017) 0.75
BAI1 is an engulfment receptor for apoptotic cells upstream of the ELMO/Dock180/Rac module. Nature (2007) 4.36
Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha(v)beta3. Circulation (2003) 3.15
Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Int J Cardiovasc Imaging (2002) 2.95
Microbubbles in ultrasound-triggered drug and gene delivery. Adv Drug Deliv Rev (2008) 2.80
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol (2008) 2.67
Microvascular recruitment is an early insulin effect that regulates skeletal muscle glucose uptake in vivo. Diabetes (2004) 2.55
Molecular imaging of inflammation in atherosclerosis with targeted ultrasound detection of vascular cell adhesion molecule-1. Circulation (2007) 2.40
Ultrasonic imaging of tumor angiogenesis using contrast microbubbles targeted via the tumor-binding peptide arginine-arginine-leucine. Cancer Res (2005) 2.34
Therapeutic arteriogenesis by ultrasound-mediated VEGF165 plasmid gene delivery to chronically ischemic skeletal muscle. Circ Res (2007) 2.14
Obesity blunts insulin-mediated microvascular recruitment in human forearm muscle. Diabetes (2006) 2.14
Assessment of endogenous and therapeutic arteriogenesis by contrast ultrasound molecular imaging of integrin expression. Circulation (2005) 2.04
Targeted tissue transfection with ultrasound destruction of plasmid-bearing cationic microbubbles. Ultrasound Med Biol (2003) 1.88
Microvascular rheology of Definity microbubbles after intra-arterial and intravenous administration. J Am Soc Echocardiogr (2002) 1.85
Ultrasound imaging of acute cardiac transplant rejection with microbubbles targeted to intercellular adhesion molecule-1. Circulation (2003) 1.83
Multimodality cardiovascular molecular imaging, Part II. Circ Cardiovasc Imaging (2009) 1.82
Binding and detachment dynamics of microbubbles targeted to P-selectin under controlled shear flow. J Control Release (2004) 1.81
Molecular imaging of the initial inflammatory response in atherosclerosis: implications for early detection of disease. Arterioscler Thromb Vasc Biol (2009) 1.79
Myocardial contrast echocardiography versus Thrombolysis In Myocardial Infarction score in patients presenting to the emergency department with chest pain and a nondiagnostic electrocardiogram. J Am Coll Cardiol (2005) 1.78
Ultrasound prevents renal ischemia-reperfusion injury by stimulating the splenic cholinergic anti-inflammatory pathway. J Am Soc Nephrol (2013) 1.76
Regional left ventricular perfusion and function in patients presenting to the emergency department with chest pain and no ST-segment elevation. Eur Heart J (2005) 1.75
Targeted-microbubble binding selectively to GPIIb IIIa receptors of platelet thrombi. Invest Radiol (2002) 1.74
Abnormal skeletal muscle capillary recruitment during exercise in patients with type 2 diabetes mellitus and microvascular complications. J Am Coll Cardiol (2009) 1.71
Molecular imaging of activated von Willebrand factor to detect high-risk atherosclerotic phenotype. JACC Cardiovasc Imaging (2010) 1.71
Molecular imaging with targeted contrast ultrasound. Curr Opin Biotechnol (2007) 1.70
Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. J Nucl Cardiol (2002) 1.68
Ultrasound-mediated vascular gene transfection by cavitation of endothelial-targeted cationic microbubbles. JACC Cardiovasc Imaging (2012) 1.63
A suggested roadmap for cardiovascular ultrasound research for the future. J Am Soc Echocardiogr (2011) 1.60
Modulating targeted adhesion of an ultrasound contrast agent to dysfunctional endothelium. Ann Biomed Eng (2002) 1.59
Monocyte and/or macrophage infiltration of heart after myocardial infarction: MR imaging by using T1-shortening liposomes. Radiology (2012) 1.58
Vascular recruitment in skeletal muscle during exercise and hyperinsulinemia assessed by contrast ultrasound. Am J Physiol Endocrinol Metab (2002) 1.56
Inhibitor of differentiation-3 mediates high fat diet-induced visceral fat expansion. Arterioscler Thromb Vasc Biol (2011) 1.54
Molecular imaging of inflammation and platelet adhesion in advanced atherosclerosis effects of antioxidant therapy with NADPH oxidase inhibition. Circ Cardiovasc Imaging (2012) 1.53
Mixed meal and light exercise each recruit muscle capillaries in healthy humans. Am J Physiol Endocrinol Metab (2006) 1.52
Acoustic radiation force enhances targeted delivery of ultrasound contrast microbubbles: in vitro verification. IEEE Trans Ultrason Ferroelectr Freq Control (2005) 1.51
Detection of coronary stenoses at rest with myocardial contrast echocardiography. Circulation (2005) 1.49
Detection of recent myocardial ischaemia by molecular imaging of P-selectin with targeted contrast echocardiography. Eur Heart J (2007) 1.47
Enhanced targeting of ultrasound contrast agents using acoustic radiation force. Ultrasound Med Biol (2007) 1.47
Phosphatidylserine receptor BAI1 and apoptotic cells as new promoters of myoblast fusion. Nature (2013) 1.45
Deformable gas-filled microbubbles targeted to P-selectin. J Control Release (2006) 1.37
Molecular imaging of endothelial vascular cell adhesion molecule-1 expression and inflammatory cell recruitment during vasculogenesis and ischemia-mediated arteriogenesis. Circulation (2008) 1.35
Targeting mucosal addressin cellular adhesion molecule (MAdCAM)-1 to noninvasively image experimental Crohn's disease. Gastroenterology (2006) 1.35
scVEGF microbubble ultrasound contrast agents: a novel probe for ultrasound molecular imaging of tumor angiogenesis. Invest Radiol (2010) 1.35
Noninvasive imaging of myocardial reperfusion injury using leukocyte-targeted contrast echocardiography. Circulation (2002) 1.34
Phagocytic activity of neuronal progenitors regulates adult neurogenesis. Nat Cell Biol (2011) 1.32
Temporal characterization of the functional density of the vasa vasorum by contrast-enhanced ultrasonography maximum intensity projection imaging. JACC Cardiovasc Imaging (2010) 1.28
Microultrasound molecular imaging of vascular endothelial growth factor receptor 2 in a mouse model of tumor angiogenesis. Mol Imaging (2007) 1.27
The vasodilatory actions of insulin on resistance and terminal arterioles and their impact on muscle glucose uptake. Diabetes Metab Res Rev (2004) 1.26
Influence of injection site, microvascular pressure and ultrasound variables on microbubble-mediated delivery of microspheres to muscle. J Am Coll Cardiol (2002) 1.25
Skeletal muscle capillary responses to insulin are abnormal in late-stage diabetes and are restored by angiotensin-converting enzyme inhibition. Am J Physiol Endocrinol Metab (2007) 1.25
Microbubbles induce renal hemorrhage when exposed to diagnostic ultrasound in anesthetized rats. Ultrasound Med Biol (2002) 1.22
Contrast echocardiography. Curr Probl Cardiol (2007) 1.22
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. Am J Gastroenterol (2008) 1.21
Targeted in vivo labeling of receptors for vascular endothelial growth factor: approach to identification of ischemic tissue. Circulation (2003) 1.21
Focused in vivo delivery of plasmid DNA to the porcine vascular wall via intravascular ultrasound destruction of microbubbles. J Vasc Res (2009) 1.19
Microbubble-enhanced ultrasound to deliver an antisense oligodeoxynucleotide targeting the human androgen receptor into prostate tumours. J Steroid Biochem Mol Biol (2006) 1.19
Echocardiographic particle image velocimetry: a novel technique for quantification of left ventricular blood vorticity pattern. J Am Soc Echocardiogr (2010) 1.17
Limb stress-rest perfusion imaging with contrast ultrasound for the assessment of peripheral arterial disease severity. JACC Cardiovasc Imaging (2008) 1.15
Dual frequency method for simultaneous translation and real-time imaging of ultrasound contrast agents within large blood vessels. Ultrasound Med Biol (2009) 1.14
Molecular imaging of atherosclerotic plaques targeted to oxidized LDL receptor LOX-1 by SPECT/CT and magnetic resonance. Circ Cardiovasc Imaging (2010) 1.14
Influence of microbubble shell properties on ultrasound signal: Implications for low-power perfusion imaging. J Am Soc Echocardiogr (2002) 1.12
Targeted delivery of nanoparticles bearing fibroblast growth factor-2 by ultrasonic microbubble destruction for therapeutic arteriogenesis. Small (2008) 1.11
Microbubbles as ultrasound contrast agents for molecular imaging: preparation and application. AJR Am J Roentgenol (2012) 1.11
Influence of microbubble surface charge on capillary transit and myocardial contrast enhancement. J Am Coll Cardiol (2002) 1.11
Extent of myocardial viability predicts response to biventricular pacing in ischemic cardiomyopathy. Heart Rhythm (2005) 1.09
Impact of revascularization and myocardial viability determined by nitrate-enhanced Tc-99m sestamibi and Tl-201 imaging on mortality and functional outcome in ischemic cardiomyopathy. J Nucl Cardiol (2002) 1.06
Effect of microbubble ligation to cells on ultrasound signal enhancement: implications for targeted imaging. Invest Radiol (2006) 1.05
Placing faith in numbers: quantification of perfusion with myocardial contrast echocardiography. J Am Coll Cardiol (2004) 1.05
Ultrasound-microbubble-induced neovascularization in mouse skeletal muscle. Ultrasound Med Biol (2005) 1.05
Imaging flow cytometry elucidates limitations of microparticle analysis by conventional flow cytometry. Cytometry A (2014) 1.04